Jan 08, 2016 12:30 pm UTC| Business
CHAPEL HILL, N.C., Jan. 08, 2016 (GLOBE NEWSWIRE) -- Bamboo Therapeutics, a biotechnology company focused on developing gene therapies for rare neurological diseases, announced today that it had acquired the viral gene...
Profound Medical Corp. Announces Publication in European Urology
Jan 08, 2016 12:10 pm UTC| Business
- TULSA-PROTM Accurately and Effectively Ablates Targeted Prostate Tissue - TORONTO, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Profound Medical Corp. (“Profound” or “Company”) (TSX-V:PRN), a medical device company developing...
Advaxis Provides 2016 Business Outlook
Jan 08, 2016 12:05 pm UTC| Business
11 Trials Evaluating Lm Technology™ Advance to Hit Multiple Development Milestones PD-1 and PD-L1 Checkpoint Combination Trials Advance to Second Phases of Evaluation Phase 3 AIM2CERV Trial to Commence in mid-2016 ...
Jan 08, 2016 12:03 pm UTC| Business
Dublin, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/2nk7kg/smart_lighting) has announced the addition of the "Smart Lighting - Global Strategic Business...
Premier Exhibitions Inc. Announces Corporate Update
Jan 08, 2016 12:00 pm UTC| Business
Strategic outlook for 2016Secures minimum US$3,000,000 note facility ATLANTA, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Premier Exhibitions, Inc. (the “Company” or “Premier”) (NASDAQ:PRXI), a leading presenter of quality...
Jan 08, 2016 12:00 pm UTC| Business
AUSTIN, Texas, Jan. 08, 2016 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ:XBIT), developer of True Human™ therapeutic antibodies, today announced that it has completed data analysis for its Phase III European study and will hold...
Otonomy to Present at J.P. Morgan Healthcare Conference
Jan 08, 2016 12:00 pm UTC| Business
SAN DIEGO, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear,...